Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?

OBJECTIVES To compare the effects of tumor volume (TV), tumor percentage involvement (TPI), and prostate volume (PV) on prostate-specific antigen (PSA) recurrence (PSAR) after radical prostatectomy (RP). METHODS A cohort of 3528 patients receiving RP between 1988 and 2008 was retrieved from the Duke Prostate Center. Patients were stratified by TV (< 3, 3-6, > 6 cm(3)), TPI (< 10%, 10%-20%, > 20%), and PV (< 35, 35-45, > 45 cm(3)) and their effects on PSAR evaluated using Kaplan-Meier analysis. Clinicopathologic variables included in univariate analysis were age at surgery, race, year of surgery, PSA, pathologic Gleason score, pathologic tumor stage, margin status, extracapsular extension, and seminal vesicle invasion. The effects of TV, TPI, and PV (as continuous and categorical variables) on PSAR were compared using Cox analysis. RESULTS TPI, TV, and PV were predictive of PSAR (P <.05) in Kaplan-Meier analysis. In multivariate analysis as continuous variables, TPI and PV were predictive of PSAR (hazard ratio [HR] = 1.16 and HR = 0.65, P <.05). As categorical variables, TPI > 20% and PV 10-35 cm(3) were predictive of PSAR (HR = 1.45 and OR = 1.25, P <.05). TV was not predictive of PSAR in either analysis. Pathologic Gleason score > or = 7, PSA, positive margins, seminal vesicle invasion, and tumor stage T3/T4 were found to be predictors of PSAR (P <.05). CONCLUSIONS TV, TPI, and PV were predictive of PSAR in univariate analysis, but in multivariate analysis, only TPI and PV were predictive of PSAR. TPI and PV should be considered when evaluating, assessing, and counseling patients regarding PSAR risk.

[1]  Seong Ki Mun,et al.  Building an accurate 3D map of prostate cancer using computerized models of 280 whole-mounted radical prostatectomy specimens , 2000, Medical Imaging.

[2]  A W Partin,et al.  Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. , 1993, The Journal of urology.

[3]  P. Humphrey,et al.  Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. , 2004, The Journal of urology.

[4]  J. Moul,et al.  Percent tumor involvement and risk of biochemical progression after radical prostatectomy. , 2008, The Journal of urology.

[5]  M. Kattan,et al.  Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. , 2006, Journal of the National Cancer Institute.

[6]  M. Peyromaure,et al.  Le faible poids de la prostate est un facteur de risque indépendant de marges chirurgicales positives sur pièce de prostatectomie radicale , 2007 .

[7]  Nancy Wells,et al.  Tumour volume is an independent predictor of prostate‐specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer , 2006, BJU international.

[8]  M. Terris,et al.  Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  N. Petrelli,et al.  Hepatic resection: the last surgical frontier for colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  F. Montorsi,et al.  A nomogram predicting long‐term biochemical recurrence after radical prostatectomy , 2008, Cancer.

[11]  L. True,et al.  Surgical pathology examination of the prostate gland. Practice survey by American society of clinical pathologists. , 1994, American journal of clinical pathology.

[12]  Robin T Vollmer,et al.  Percentage of tumor in prostatectomy specimens: a study of American Veterans. , 2009, American journal of clinical pathology.

[13]  A. Wein,et al.  Campbell-Walsh Urology , 2011 .

[14]  A. Tewari,et al.  Prostate volume and the incidence of extraprostatic extension: is there a relation? , 2009, Journal of endourology.

[15]  Michael W Kattan,et al.  Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Jason C. Massengill,et al.  Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. , 2003, The Journal of urology.

[17]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[18]  J. Moul,et al.  Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy , 2008, Prostate Cancer and Prostatic Diseases.

[19]  A. D'Amico,et al.  A prostate gland volume of more than 75 cm3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer. , 1999, Urology.

[20]  Emil A. Tanagho,et al.  Smith's General Urology , 1996 .

[21]  T. Stamey,et al.  Biological determinants of cancer progression in men with prostate cancer. , 1999, JAMA.

[22]  Anthony V D'Amico,et al.  Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. , 2007, The Journal of urology.

[23]  R. Kirby,et al.  A large prostate at radical retropubic prostatectomy does not adversely affect cancer control, continence or potency rates , 2003, BJU international.

[24]  V Loy,et al.  Visual estimation of the tumor volume in prostate cancer: a useful means for predicting biochemical-free survival after radical prostatectomy? , 2007, Prostate Cancer and Prostatic Diseases.

[25]  C. Magi-Galluzzi,et al.  Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. , 2007, Urology.

[26]  P. Humphrey,et al.  Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy , 2000, Cancer.

[27]  T. Stamey,et al.  Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. , 2000, The Journal of urology.

[28]  P. Scardino,et al.  Is tumor volume an independent prognostic factor in clinically localized prostate cancer? , 2004, The Journal of urology.

[29]  François Bénard,et al.  Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. , 2007, European journal of cancer.

[30]  A. D'Amico,et al.  Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality. , 2006, Urology.

[31]  A. Haese*,et al.  Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy , 2006, Cancer.

[32]  Thomas M. Wheeler,et al.  A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer , 1998 .